Radioreductive Effect of Bestatin (Ubenimex) in BALB/c Mice

References

• Abe F., Shibuya K., Uchida M., Takahashi K., Horinishi H., Matsuda A., Ishizuka M., Takeuchi T., Umezawa H. Effect of Bestatin on syngeneic tumors in mice. Gann 1984; 75: 89–94
   PubMedGoogle Scholar
• Aoki Y. Protective action of OK-432 (Picibanil) on the radiation induced myelosuppression. Nippon Acta Radiologica 1986; 46: 1324–1330, (in Japanese)
   PubMedGoogle Scholar
• Behling U.H. The radioprotective effect of bacterial endotoxin. Beneficial Effect of Endotoxin, A. Nowotny. Academic Press, New York 1983; 127–148, In
   Google Scholar
• Bruley-Rosset M., Florentin I., Kinger N., Shulz J., Mathe G. Restoration of impaired immune functions of aged animals by chronic Bestatin treatment. Immunology 1979; 38: 75–83
   PubMed Web of Science ®Google Scholar
• Hall E.J. Radiobiology for the Radiologist2nd edn. Harper & Row, New York 1987; 203–215
   Google Scholar
• Ishizuka M. Ubenimex, a low molecular weight immunomodifier: discovery and action. 16th International Congress of Chemotherapy, JerusalemIsrael, 1989; 8–8, (abstr.)
   Google Scholar
• Ishizuka M., Matsuda T., Mizutani S., Takeuchi T., Umezawa H. Antitumor cells found in tumor-bearing mice given Ubenimex. Journal of Antibiotics 1987; 60: 697–701
   Google Scholar
• Kimura I. Effect of Bestatin on hematopoiesis. Cancer Treatment Reviews 1980; 7: 257–260
   PubMed Web of Science ®Google Scholar
• Mathé G., Blazsek L., Florentin I. Bestatin, an immunostimulator and an immunoregulator (with CD4+CD8-as a first target?). 16th International Congress of Chemotherapy, JerusalemIsrael, 1989; 9–9, (abstr.)
   Google Scholar
• Nemoto K., Abe F., Karakawa K., Horinishi H., Umezawa H. Enhancement of colony formation of mice bone marrow cells by Ubenimex. Journal of Antibiotics 1987; 60: 894–898
   Google Scholar
• Neta R., Douches S.D., Oppenheim J.J. Interleukin 1 is a radioprotector. Journal of Immunology 1986a; 136: 2483–2485
   PubMed Web of Science ®Google Scholar
• Neta R., Douches S.D., Oppenheim J.J. Strain dependence of mice to radioprotective effect of IL-1. 6th International Congress of Immunology, TorontoCanada, 1986b; 488–488, (abstr.)
   Google Scholar
• Neta R., Oppenheim J.J. Cytokines in therapy of radiation injury. Blood 1988; 72: 1093–1095
   PubMed Web of Science ®Google Scholar
• Ohara N., Okamura S., Niho Y., Ostuka T. Stimulatory effect of an aminopeptidase inhibitor on human bone marrow CFU-C mediated by the interaction of T-lymphocyte. Acta Hematologica Japonica 1985; 48: 1012–1016
   Web of Science ®Google Scholar
• Okamura S., Omori F., Haga K., Baba H., Kawasaki C., Tanaka T., Sugimati K., Niho Y. Ubenimex stimulates production of colony-stimulating factor from human peripheral mononuclear cells in vitro. 16th International Congress of Chemotherapy, JerusalemIsrael, 1989; 9–9, (abstr.)
   Google Scholar
• Rasey J.S., Nelson N.J., Mahler P., Anderson K., Krohn K.A., Menard T. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution. Radiation Research 1984; 97: 598–607
   PubMed Web of Science ®Google Scholar
• Saito Y., Uzuka Y. Bestatin treatment of patients with myelodysplastic syndrome (MDS) and the effect of Bestatin on hematopoiesis in MDS. 16th International Congress of Chemotherapy, JerusalemIsrael, 1989; 9–9, (abstr.)
   Google Scholar
• Shibuya K., Hayashi E., Abe F., Takahashi K., Horinishi H., Ishizuka M., Takeuchi T., Umezawa H. Enhancement of interleukin 1 and interleukin 2 releases by Ubenimex. Journal of Antibiotics 1987; 60: 363–369
   Google Scholar
• Talmadge J.E., Black P.L., Pelus L.M., Abe F. Hematopoietic and hematologic properties of Bestatin in normal and cyclophosphamide myelosuppressed mice. Biomedical and Pharmacotherapy 1990; 44: 85–91
   PubMed Web of Science ®Google Scholar
• Tanikawa S., Nakao I., Tseuneoka K., Nara N. Effect of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice. Experimental Hematology 1989; 17: 883–888
   PubMed Web of Science ®Google Scholar
• Tanikawa S., Nose M., Aoki Y., Tsuneoka K., Shikita M., Nara N. Effect of recombinant human granulocyte colony-stimulating factor on the hematologic recovery and survival of irradiated mice. Blood 1990; 76: 445–449
   PubMed Web of Science ®Google Scholar
• Till J.E., McCulloch E.A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiation Research 1961; 14: 213–222
   PubMed Web of Science ®Google Scholar
• Tsunogane S., Furusawa S., Takano H., Shishido H., Abe F. Effect of Ubenimex on the proliferation of normal human hematopoietic cells and myeloid leukemia cells. International Congress of Chemotherapy, JerusalemIsrael, 1990; 98–98, (abstr.)
   Google Scholar
• Uckun F.M., Souza L., Wassick K.G., Wick M., Song C.W. In vivo radioprotective effects of recombinant human granulocyte colony-stimulating factor in lethally irradiated mice. Blood 1990; 75: 638–645
   PubMed Web of Science ®Google Scholar
• Umezawa H., Aoyagi T., Suda H., Hamada M., Takeuchi T. Bestatin, an inhibitor of aminopeptidase B produced by actinomycetes. Journal of Antibiotics 1976; 29: 97–99
   PubMed Web of Science ®Google Scholar
• Wu S.G., Tuboi A., Miyamoto T. Radioprotection of C3H mice by recombinant human interleukin-1. International Journal of Radiation Biology 1989; 56: 485–492
   PubMed Web of Science ®Google Scholar